Dear Colleagues,
Endorsed and supported by Chinese Biopharmaceutical Association(CBA) and SAPA-GP, we’d like to invite you to participate in Biologics Innovation and Frontier Technology (BIFT China 2020, www.biftsummit.com) to be held on December 9 and 10, 2020 in Shanghai, China, a branded Biopharma R&D and Bioprocessing Summit in China well attended by world leading biopharma and biotech companies and top CDMO, CRO and research institutes in China and Asia.
As a premier bioinnovation and bioprocessing event in China, the 4th Biologics Innovation and Frontier Technology (BIFT) China Summit 2020 will attract 600+ senior level attendees and feature higher speaker lineup, deeper insights, and real technical case studies from leading biopharma and GCT players in China. Comprehensive topics will cover development of the next generation of new therapeutic biological products in China (antibodies, cell products, gene therapy virus products), bispecific antibodies development and CMC strategies, Antibody-Drug Conjugates development, cell line and upstream process development, viral safety and clearance of biologics, downstream processing, single-use systems, continuous production, contract manufacturing, cGMP manufacturing quality control etc.
Snapshots of BIFT China 2020
- Recent Trends and Development for Antibody Therapeutics in China
- Novel Antibody Development and Immuno-Oncology
- Clinical Trial Design, Combination Therapy for Innovative Biologics Trails
- Innovative Platform for Bispecific Antibody Discovery and Engineering
- Antibody-Drug Conjugates Development and Production
- Advancement in Cell Line Development and Clone Selection Technologies
- Quality Control, Protein Characterization, cGMP and Contract Manufacturing
- Innovative Bio-manufacturing Technologies (including Continuous Processing, Single-use Systems and QbD/PAT)
- Biologics Formulation, Aggregation and Stability Studies
- Next-gen Innovative Cell & Gene Therapeutics Development (CAR-T, TCR-T, TIL, AAV…)
- Viral and Cell therapy CMC, GMP Production and Quality Control
Eminent Speakers and VIPs in BIFT China 2020
Ning Li, General Manager, Junshi Pharma
Scott Liu, President, Henlius Bio
Qinwei Zhou, COO, Innovent Bio
Zhenping Zhu, President R&D, 3S Bio
Haibin Wang, Senior Vice President, Hisun Pharma
Tongtong Xue , CEO, Kelun Biotech
Charlie Qi, Oncology head, Roche China
Biao Zhen, CSO, GenFleet Therapeutics
Robert Zhao, CEO & Chairman, Hangzhou DAC Biotech
Mary Hu, CEO, Miracogen Inc.
Yi Zhang, Director, Biotherapy Center, The First Affiliated Hospital of Zhengzhou University
James Li, CEO, JW Therapeutics
Lulu Lv, CEO, Juventas
Min Luo, CSO, Bio-gene
Feifei Qi, CTO, Immunochina
Lietao Li, CEO, BioSyngen
Hangwen Li, CEO, Stemirna Therapeutics
Ming Wang, President & CEO, Phanes Therapeutics
Xinpo Jiang, Senior Director, Legend Biotech
Bin Li, Deputy Director, Shanghai Institute of Immunology
etc…
Why BIFT China 2020
■500+ delegates from over 10 countries and regions
■100+ attending organizations
■40+ eminent speakers from biopharma, biotech and bioprocess companies
■70% on average attendees from primary market (biopharmas, CROs, CMOs etc)
■60% above company decision making and director level
■1 main conference and 4 focused streams
Pictures of BIFT China 2019
Partial Top Participating Biopharmas in China and Asia
Alphamab | Kanda Biotech |
Askesobio | LG Life Sciences |
Astra Zeneca | Livzon Mab |
Beigene | Luye Pharma |
Biocon India | Mabspace |
Boehringer Ingelheim (China) AVRDC | Mabventure |
Boehringer Ingelheim (China) Biopharma | Newsummit Bio |
Celltrion | Remegen Bio |
CPGP Pharma | Samsung Bioepis |
Destiny Bio | Shanghai Acebright Pharma |
Dingfu Bio | Shanghai Benemae Pharmaceutical |
EirGenix | Shanghai Biomab |
Fudan Zhangjiang Bio | Shanghai Institute of Biological Products |
Furen Bio | Simcere |
Genrix Bio | Syndegen |
Gmax Biopharma | Tasly Pharma (Shanghai) |
Haiyan Pharma | Teruisi Pharma |
Henlius Bio | T-mab Bio |
Henri Medicine Shanghai | TOT Biopharma |
Hisun Pharma | United Biomedical |
Huabo Bio | Walvax Genor Bio |
Hualan Bio | Wuxi Apptec |
Huaota Bio | YZY Bio |
Innovent Bio | Zerun Bio |
JHL Bio | Zhangjiang Biotechnology |
For more information, feel free to contact the organizing committee at 8621-31123968